Asset Publisher

angle-left Elham Rahme, PhD

Scientist, RI-MUHC, 5252 de Maisonneuve

Metabolic Disorders and Complications Program

Associate Professor, Department of Medicine, Division of Clinical Epidemiology, Faculty of Medicine, McGill University



drug utilisation • drug safety • health services research • database studies • risk of suicide

Research Focus

My research focuses on the evaluation of the safety, effectiveness, and economic implications of prescribed medications. I have conducted population-based studies to assess the utilization, adverse events, and cost of nonsteroidal anti-inflammatory drugs, risks and benefits of extended outpatient anticoagulant use following total hip and knee arthroplasty, and home care following hospital discharge from hemiarthroplasty. Other studies include the use of serotonin re-uptake inhibitors in association with the risk of suicide and risk of bleeding, and risk and determinants of attempted suicide in Quebec. I have also conducted research on the rate of infection and development of multi-drug resistance in patients undergoing dialysis, estimation of the prevalence of diagnosed and undiagnosed diabetes in Quebec, as well as utilisation, safety and cost of anti-TNF-alpha drugs in rheumatoid arthritis, ankylosing spondilitis, Chron's disease and ulcerative colitis patients, and assessment and development of biostatistics' methods for pharmacoepidemiology research.

Selected Publications

Click on Pubmed to see my current publications list

  • Leong A, Dasgupta K, Chiasson JL, Rahme E. Estimating the population prevalence of diagnosed and undiagnosed diabetes. Diabetes Care. 2013 Oct;36(10):3002-8. PMID: 23656982.

  • Rahme E, Roussy JP, Woolcott J, Nedjar H, Barkun A. Mortality and readmission rates after hospitalization for upper and lower gastrointestinal events in Quebec, Canada.J Clin Gastroenterol. 2013 Aug;47(7):586-92. PMID: 23426460.

  • Rahme E, Feugère G, Sirois C, Weicker S, Ramos E.Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.Thromb Res. 2013 Mar;131(3):210-7. PMID: 23290095.

  • Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E. CMAJ. 2011 Nov 8;183(16):1835-43. PMID: 21948719.

  • Short-term mortality associated with failure to receive home care after hemiarthroplasty. Rahme E, Kahn SR, Dasgupta K, Burman M, Bernatsky S, Habel Y, Berry G. CMAJ. 2010 Sep 21;182(13):1421-6. PMID: 20713576.